warnings
Warnings For external use only.
BP Acne Spot Treatment
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- BP Acne Spot Treatment
- Generic name
- ACNE SPOT TREATMENT
- Manufacturer
- Skin PS Brands
- Product type
- HUMAN OTC DRUG
- SPL set ID
- feb0ed89-878b-2497-e053-6394a90ad1c1
- SPL ID
- 4736d20b-326f-5478-e063-6294a90ada87
- Version
- 3
- Effective date
- 2025-12-30
- Source export date
- 2026-09-28
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:34:59
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M006 | openfda.application_number | |
| brand name | BP Acne Spot Treatment | openfda.brand_name | |
| generic name | ACNE SPOT TREATMENT | openfda.generic_name | |
| manufacturer name | Skin PS Brands | openfda.manufacturer_name | |
| ndc | package | 73318-7002-5 | openfda.package_ndc |
| ndc | product | 73318-7002 | openfda.product_ndc |
| ndc11 | package | 73318700205 | derived:openfda.package_ndc |
| rxcui | 106310 | openfda.rxcui | |
| spl id | 4736d20b-326f-5478-e063-6294a90ada87 | id | |
| spl set id | feb0ed89-878b-2497-e053-6394a90ad1c1 | set_id | |
| unii | W9WZN9A0GM | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.